1. ADME/PK as part of a rational approach to drug discovery;Eddershaw;Drug Discov Today,2000
2. Lead optimization in discovery drug metabolism and pharmacokinetics/case study: the Hepatitis C Virus (HCV) protease inhibitor SCH 503034;Cheng;Perspect Med Chem,2007
3. Lead optimization in discovery drug metabolism and pharmacokinetics/case study: the Hepatitis C Virus (HCV) protease inhibitor SCH 503034;Cheng,2011
4. On the dissemination of novel chemistry and the process of optimising compounds in drug discovery projects;Ashenden,2019
5. Oral formulations for preclinical studies: principle, design, and development considerations;Gao,2016